Home > Boards > US Listed > Biotechs > MannKind Corp. (MNKD)

News this week?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BluSkies Member Profile
 
Followed By 199
Posts 18,132
Boards Moderated 0
Alias Born 11/10/12
160x600 placeholder
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 9:00:00 AM
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD GlobeNewswire Inc. - 9/19/2019 9:00:00 AM
MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 8/30/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:08:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:02:50 PM
MannKind Corporation Reports 2019 Second Quarter Financial Results and Recent Business Highlights GlobeNewswire Inc. - 8/7/2019 4:01:00 PM
MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One ... GlobeNewswire Inc. - 8/5/2019 9:00:00 AM
MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019 GlobeNewswire Inc. - 8/1/2019 5:02:20 PM
Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3 GlobeNewswire Inc. - 7/31/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 9:11:39 AM
MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants GlobeNewswire Inc. - 7/18/2019 8:52:49 AM
MannKind Partners with GoodRx to Help Raise Awareness on Reducing Out of Pocket Insulin Cost for Patients GlobeNewswire Inc. - 7/15/2019 9:00:00 AM
MannKind Expands Commercial Scale Manufacturing Capabilities for High-Potency Molecules GlobeNewswire Inc. - 7/11/2019 4:14:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 6:07:20 AM
MannKind to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 9:00:00 AM
MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions GlobeNewswire Inc. - 6/9/2019 2:00:00 PM
Afrezza® (insulin human) Inhalation Powder Approved in Brazil GlobeNewswire Inc. - 6/3/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:41:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:31:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:30:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:29:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:28:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:28:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:27:36 PM
BluSkies   Monday, 03/25/19 10:13:35 AM
Re: None
Post # of 31687 
News this week?

The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist